Iterum Therapeutics plc ( ITRMF) - Stock Earnings
ITRMF Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| June 16, 2026, midnight | — / — | — | — / — | — |
ITRMF Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q4 | -3.1 million USD | — USD |
| 2025Q3 | — USD | 390000 USD |
| 2026Q2 Est. | — | — |
ITRMF Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -22.9 million USD | — USD |
| 2023 | -43.8 million USD | — USD |
| 2024 | -17.6 million USD | — USD |
| 2026 Est. | — | — |
ITRMF
Price: $0.04
52 week price:
Earnings Per Share: -0.34 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 3.0 million